(Q77452744)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785054%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

review article

1 reference

title

Clinical trials of reducing low-density lipoprotein concentrations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785054%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

B M Rifkind

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785054%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785054%20AND%20SRC:MED&resulttype=core&format=json

Endocrinology and Metabolism Clinics of North America

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785054%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785054%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

585-95, viii-ix

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785054%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785054%20AND%20SRC:MED&resulttype=core&format=json

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Consensus conference. Lowering blood cholesterol to prevent heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Cholesterol screening guidelines. Consensus, evidence, and common sense

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Health policy on blood cholesterol. Time to change directions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Cataracts in Patients Treated with Triparanol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Carcinogenicity of lipid-lowering drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Is cholesterol reduction always safe?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Serum cholesterol--the knave of hearts and the joker

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Lipid-lowering interventions in angiographic trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970027-X

7 January 2021

10.1016/S0889-8529(05)70027-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785054%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference